SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-24-000147
Filing Date
2024-08-07
Accepted
2024-08-06 17:37:18
Documents
98
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ebs-20240630.htm   iXBRL 10-Q 2051283
2 EX-31.1 a311-papacert063024.htm EX-31.1 8501
3 EX-31.2 a312-lindahlcert063024.htm EX-31.2 8561
4 EX-32.1 a321-papacert063024.htm EX-32.1 3437
5 EX-32.2 a322-lindahlcert063024.htm EX-32.2 3387
11 ebs-20240630_g1.jpg GRAPHIC 75656
  Complete submission text file 0001367644-24-000147.txt   10782606

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20240630.xsd EX-101.SCH 57587
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebs-20240630_cal.xml EX-101.CAL 92260
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebs-20240630_def.xml EX-101.DEF 367154
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20240630_lab.xml EX-101.LAB 726510
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20240630_pre.xml EX-101.PRE 587941
101 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20240630_htm.xml XML 1891045
Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 241180677
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)